What Gets Injected in Hair Mesotherapy? The Gupta 2023 Systematic Review

What does the science on hair mesotherapy actually show when you look at all of it at once, not just one promising trial? A 2023 systematic review led by Dr. Aditya Gupta of the University of Toronto did exactly that: the team screened 416 records and analysed the 27 studies that met their quality criteria. The picture that emerges is encouraging but unfinished. Several studies report statistically significant hair growth improvements across six classes of agents, and yet the field still lacks a standard recipe for how mesotherapy should be done.

Study by Gupta, Polla Ravi, Wang, Talukder, Starace and Piraccini, published in the Journal of Dermatological Treatment (2023). Summarised by Malcolm Smith, Founder of Hairgenetix. Medically reviewed by Dr. Esther Bodde, MD, Cosmetic & Plastic Surgeon. Last updated 2 September 2026.

Quick answer
  • 27 studies made the cut out of 416 records screened, making this one of the broadest overviews of hair mesotherapy published to date.
  • Six agent classes have been studied: dutasteride, minoxidil, growth factors, botulinum toxin A, stem cells, and multivitamin mesh solutions, plus combinations of these.
  • Several studies report statistically significant hair growth improvements, but the review found no standardized regimens: doses, intervals and protocols vary from study to study.
  • Adverse effects have been reported after mesotherapy, so agent choice and technique matter. The authors call for larger controlled trials.

This article is part of our complete guide to hair mesotherapy.

Why does this review matter?

Most articles about mesotherapy for hair loss lean on a single study, which makes cherry-picking easy. A systematic review solves this by finding every study that meets predefined quality criteria and summarising the whole field in one place.

The idea being tested is simple. Mesotherapy delivers low doses of therapeutic agents directly into the skin through intradermal injections. Because the agent is placed where it is needed, it stays in the affected area longer, which the authors note allows lower doses and longer gaps between sessions, and may improve both results and how easily patients stick with treatment. Whether that promise holds up depends on what is in the syringe, which is why a class-by-class overview is so useful. For readers comparing home setups, our at-home mesotherapy kit comparison covers the practical side.

What did the review cover?

The team searched the literature and identified 416 records, then applied their inclusion criteria and kept 27 articles. Across those studies, six classes of agents and their combinations have been used in hair mesotherapy, and the review summarised the efficacy results observed for each. The author list combines Dr. Gupta's Toronto research group with the dermatology unit of the University of Bologna, two teams with long track records in hair loss research.

What does the field show, class by class?

Agent class What it is
Dutasteride A hormone-pathway blocker, delivered in microdoses to the scalp instead of as a daily pill
Minoxidil The best-known topical hair growth drug, injected rather than applied to the surface
Growth factors Signalling proteins, including autologous preparations made from the patient's own blood
Botulinum toxin A The muscle-relaxing agent better known from cosmetic injections
Stem cells Cell-based preparations intended to stimulate the follicle environment
Mesh solutions and multivitamins Vitamin and nutrient cocktails, the oldest and least standardized category

Across these classes, the headline finding is that several studies report statistically significant improvements in hair growth after treatment. Mesotherapy is not a fringe idea resting on anecdotes.

The dutasteride branch is the one we have covered most closely on this blog. An early study by Moftah and colleagues examined dutasteride mesotherapy in women with female pattern hair loss, and a decade later a real-world study of 541 patients reported on the same approach at clinical scale. Both sit inside the landscape this review maps.

The equally important finding is what the field does not have: standardized regimens. Studies differ in agent, dose, depth, frequency and duration, so a positive result with one protocol does not automatically transfer to a different clinic using a different cocktail on a different schedule.

What about safety?

The review is direct about this: adverse effects after mesotherapy have been reported. It does not quantify them by agent or frequency, so the honest summary is that mesotherapy is an injection technique, injections carry risks, and the risk profile depends on what is injected and by whom. That is a reason to prefer well-characterised agents and careful technique, not to dismiss the method.

Limitations to keep in mind

A systematic review is only as strong as the studies inside it, and the authors' own conclusion is telling: further large-scale, controlled clinical trials are warranted. Without standardized regimens, the 27 studies cannot be pooled into a single effect size. That is why this article gives you no overall percentage improvement: none exists yet, and any article that quotes one for mesotherapy as a whole is inventing it. What the review supports is a more modest claim: the technique is promising, several agents have significant results behind them, and the field needs bigger and better trials.

What does this mean for your routine?

Three practical lessons follow. First, the delivery principle behind mesotherapy is sound: getting an active agent into the scalp, rather than just onto it, is the common thread across all six agent classes. Second, the agent matters more than the needle, so choose ingredients you can identify and check. Third, because protocols are not standardized, ask any provider exactly what is in their cocktail and what evidence supports it.

If you want the delivery principle without injections, our at-home hair mesotherapy kit applies the same logic of targeted scalp delivery in a form you control yourself. Our hair mesotherapy guide covers the technique, evidence and safety questions step by step.

Frequently asked questions

Does mesotherapy work for hair loss?

The evidence is promising but incomplete. In this systematic review of 27 studies, several report statistically significant hair growth improvements. However, regimens are not standardized and the authors call for larger controlled trials.

Which agents have been studied in hair mesotherapy?

Six classes and their combinations: dutasteride, minoxidil, growth factors or autologous suspensions, botulinum toxin A, stem cells, and mesh solutions or multivitamins.

Why does mesotherapy use lower doses than pills?

Intradermal injection places the agent directly in the affected area, where it stays longer. According to the review, this allows lower doses and longer intervals between sessions, which may improve outcomes and compliance.

Is hair mesotherapy safe?

Adverse effects have been reported, and the review does not quantify how common they are. Risk depends on the agent and the technique, so treat provider choice and ingredient transparency as part of the safety decision.

Is there a standard mesotherapy protocol for hair loss?

No. The review's central criticism is the lack of standardized regimens: studies vary in agent, dose, frequency and duration, which makes results hard to compare between clinics.

References

1. Gupta AK, Polla Ravi S, Wang T, Talukder M, Starace M, Piraccini BM. "Systematic review of mesotherapy: a novel avenue for the treatment of hair loss." Journal of Dermatological Treatment, 2023. PubMed 37558233.

2. Moftah N, et al. "Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation." Journal of the European Academy of Dermatology and Venereology, 2013. PubMed 22486925.

3. Saceda-Corralo D, et al. "Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice." Journal of Drugs in Dermatology, 2022. PubMed 35816059.

Powrót do Articles